glp-3 vs retatrutide is a “GLP-3” therapy, meaning it acts on three hormone receptors — GLP-1, GIP, and glucagon — to influence appetite regulation, blood sugar control, and energy expenditure. By working across these Triple G pen 20 mg

Peptides show promise warranting careful use but shouldn't replace proven treatments or create unrealistic miracle cure expectations

Referral to an endocrinologist or specialist obesity clinic is particularly important if there is a suspected hormonal deficiency or if standard lifestyle measures have not achieved adequate weight management

Currently approved and commonly used GLP-1R agonists include exenatide (the synthetic form of Ex-4, a naturally occurring GLP-1R agonist), lixisenatide, dulaglutide liraglutide and semaglutide ( Figure 2 ) (17, 110)

Abstract Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective for glycaemic control and weight loss in patients with type 2 diabetes (T2D)